skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 134  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
Material Type:
Article
Add to My Research

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494

Digital Resources/Online E-Resources

2
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
Material Type:
Article
Add to My Research

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

New England Journal of Medicine, 2023-01, Vol.388 (2), p.183-185 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2214293 ;PMID: 36546661

Digital Resources/Online E-Resources

3
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Material Type:
Article
Add to My Research

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nature communications, 2021-06, Vol.12 (1), p.3587-3587, Article 3587 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-23942-y ;PMID: 34117252

Full text available

4
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
Material Type:
Article
Add to My Research

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

New England Journal of Medicine, 2022-03, Vol.386 (11), p.1088-1091 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119912 ;PMID: 35081298

Digital Resources/Online E-Resources

5
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Material Type:
Article
Add to My Research

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant

Cell host & microbe, 2021-04, Vol.29 (4), p.516-521.e3 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.03.009 ;PMID: 33798491

Full text available

6
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood
Material Type:
Article
Add to My Research

Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood

Emerging infectious diseases, 2017-01, Vol.23 (1), p.99-101 [Peer Reviewed Journal]

COPYRIGHT 2017 U.S. National Center for Infectious Diseases ;COPYRIGHT 2017 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2301.161394 ;PMID: 27748649

Full text available

7
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
Material Type:
Article
Add to My Research

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

Nature immunology, 2021-10, Vol.22 (10), p.1306-1315 [Peer Reviewed Journal]

2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. ;COPYRIGHT 2021 Nature Publishing Group ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01021-0 ;PMID: 34417590

Full text available

8
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Material Type:
Article
Add to My Research

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Nature, 2009-03, Vol.458 (7235), p.206-210 [Peer Reviewed Journal]

2009 INIST-CNRS ;COPYRIGHT 2009 Nature Publishing Group ;COPYRIGHT 2009 Nature Publishing Group ;Copyright Nature Publishing Group Mar 12, 2009 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;EISSN: 1476-4679 ;DOI: 10.1038/nature07662 ;PMID: 19078956 ;CODEN: NATUAS

Full text available

9
Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant
Material Type:
Article
Add to My Research

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant

Cell Reports Medicine, 2022-07, Vol.3 (7), p.100679-100679, Article 100679 [Peer Reviewed Journal]

2022 ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Authors 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100679 ;PMID: 35798000

Digital Resources/Online E-Resources

10
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Material Type:
Article
Add to My Research

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Immunity (Cambridge, Mass.), 2021-03, Vol.54 (3), p.542-556.e9 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2021.02.001 ;PMID: 33631118

Full text available

11
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
Material Type:
Article
Add to My Research

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

Cell reports. Medicine, 2022-02, Vol.3 (2), p.100529-100529, Article 100529 [Peer Reviewed Journal]

2022 ;2022. ;2022. 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100529 ;PMID: 35233550

Full text available

12
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1
Material Type:
Article
Add to My Research

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

The Lancet infectious diseases, 2012-12, Vol.12 (12), p.966-976 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(12)70243-8 ;PMID: 23174382 ;CODEN: LANCAO

Full text available

13
Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans
Material Type:
Article
Add to My Research

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

Proceedings of the National Academy of Sciences - PNAS, 2020-07, Vol.117 (30), p.17957-17964 [Peer Reviewed Journal]

Copyright National Academy of Sciences Jul 28, 2020 ;2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1906613117 ;PMID: 32661157

Full text available

14
Durability of immune responses to mRNA booster vaccination against COVID-19
Material Type:
Article
Add to My Research

Durability of immune responses to mRNA booster vaccination against COVID-19

The Journal of clinical investigation, 2023-05, Vol.133 (10), p.1-10 [Peer Reviewed Journal]

COPYRIGHT 2023 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2023 ;2023 Arunachalam et al. 2023 Arunachalam et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI167955 ;PMID: 36951954

Full text available

15
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
Material Type:
Article
Add to My Research

Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection

PloS one, 2021-08, Vol.16 (8), p.e0256482-e0256482 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;2021 Lapp et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Lapp et al 2021 Lapp et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0256482 ;PMID: 34449792

Full text available

16
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial
Material Type:
Article
Add to My Research

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.1210-1220 [Peer Reviewed Journal]

Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00052-4 ;PMID: 35568049

Full text available

17
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

npj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518

Full text available

18
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
Material Type:
Article
Add to My Research

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

The Journal of infectious diseases, 2011-03, Vol.203 (5), p.610-619 [Peer Reviewed Journal]

Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011 ;2015 INIST-CNRS ;ISSN: 0022-1899 ;ISSN: 1537-6613 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiq105 ;PMID: 21282192 ;CODEN: JIDIAQ

Full text available

19
Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
Material Type:
Article
Add to My Research

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection

The Journal of clinical investigation, 2022-12, Vol.132 (23), p.1-3 [Peer Reviewed Journal]

COPYRIGHT 2022 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Dec 2022 ;2022 Linderman et al. 2022 Linderman et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI164303 ;PMID: 36256473

Full text available

20
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Material Type:
Article
Add to My Research

Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

The Journal of infectious diseases, 2011-07, Vol.204 (1), p.164-173 [Peer Reviewed Journal]

Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011 ;2015 INIST-CNRS ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jir199 ;PMID: 21628671 ;CODEN: JIDIAQ

Full text available

Results 1 - 20 of 134  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (76)

Refine My Results

Creation Date 

From To
  1. Before 2004  (5)
  2. 2004 To 2010  (5)
  3. 2011 To 2014  (20)
  4. 2015 To 2019  (26)
  5. After 2019  (79)
  6. More options open sub menu

Resource Type 

  1. Articles  (86)
  2. Patents  (48)
  3. More options open sub menu

Language 

  1. Chinese  (39)
  2. Japanese  (14)
  3. French  (5)
  4. German  (2)
  5. More options open sub menu

Searching Remote Databases, Please Wait